Filing Details
- Accession Number:
- 0000930413-11-007260
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-10 17:05:50
- Reporting Period:
- 2011-11-08
- Filing Date:
- 2011-11-10
- Accepted Time:
- 2011-11-10 17:05:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 727510 | Enzon Pharmaceuticals Inc | ENZN | Biological Products, (No Disgnostic Substances) (2836) | 222372868 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1526633 | Aby Buchbinder | C/O Enzon Pharmaceuticals, Inc. 20 Kingsbridge Road Piscataway NJ 08854 | Vp, Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-11-08 | 2,700 | $7.06 | 54,015 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
